Made in Europe: will artemisinin resistance emerge in French Guiana?

Abstract : Resistance to artemisinin casts a shadow on the fight against malaria. The importance of illegal gold miners and of malaria in isolated regions of French Guiana constitutes a threat that endangers the fight against malaria in the Amazon. The hurdles of French laws and the remoteness of the territory from France make it impossible for the system to adapt to the problem of total inaccessibility of an important part of the malaria problem. Transmission is high in these areas and gold miners self-medicate with erratic regimens of artemisinin combinations, thus creating perfect conditions for the emergence of resistance. What needs to be done is being done, but within the limits of national law, with some results. However, facing the same difficult problem, Suriname shows more flexibility and is doing much better than French Guiana despite having lower resources. Local authorities in French Guiana cannot overrule the laws that block appropriate malaria care from reaching a third of malaria-exposed persons. Thus the health authorities in France should take immediate calibrated legislative and financial measures to avoid a predictable disaster.
Type de document :
Article dans une revue
Malaria Journal, BioMed Central, 2013, 12, pp.152. 〈10.1186/1475-2875-12-152〉
Liste complète des métadonnées

Littérature citée [16 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00838961
Contributeur : Antoine Adenis <>
Soumis le : mercredi 26 juin 2013 - 19:39:44
Dernière modification le : mardi 6 mars 2018 - 19:36:01
Document(s) archivé(s) le : vendredi 27 septembre 2013 - 10:40:42

Fichier

Nacher_et_al._Malaria_J.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

Citation

Mathieu Nacher, Philippe Guérin, Magalie Demar-Pierre, Félix Djossou, François Nosten, et al.. Made in Europe: will artemisinin resistance emerge in French Guiana?. Malaria Journal, BioMed Central, 2013, 12, pp.152. 〈10.1186/1475-2875-12-152〉. 〈inserm-00838961〉

Partager

Métriques

Consultations de la notice

402

Téléchargements de fichiers

90